• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Down Over 1%; Merck Increases 2024 Outlook

    4/25/24 12:04:30 PM ET
    $ATNI
    $HTZ
    $MRK
    $ORN
    Telecommunications Equipment
    Telecommunications
    Rental/Leasing Companies
    Consumer Discretionary
    Get the next $ATNI alert in real time by email

    U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by around 250 points on Thursday.

    The Dow traded down 1.55% to 37,864.79 while the NASDAQ fell 1.60% to 15,460.95. The S&P 500 also fell, dropping, 1.16% to 5,012.94.

    Check This Out: How To Earn $500 A Month From T-Mobile US Stock Ahead Of Q1 Earnings Report

    Leading and Lagging Sectors

    Energy shares fell by just 0.2% on Thursday.

    In trading on Thursday, communication services shares dipped by 5.3%.

    Top Headline

    Merck & Co., Inc. (NYSE:MRK) reported better-than-expected first-quarter financial results and raised its 2024 guidance.

    Merck posted adjusted earnings of $2.07 per share, beating market estimates of $1.88 per share. The company's sales came in at $15.775 billion versus expectations of $15.196 billion.

    Equities Trading UP
                           

    • Impinj, Inc. (NASDAQ:PI) shares shot up 17% to $141.91 after reporting better-than-expected first-quarter financial results.
    • Shares of Ultralife Corporation (NASDAQ:ULBI) got a boost, surging 18% to $10.33 after the company reported better-than-expected quarterly financial results.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) shares were also up, gaining 52% to $2.4550 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.

    Equities Trading DOWN

    • ATN International, Inc. (NASDAQ:ATNI) shares dropped 30% to $20.12 as the company posted weak quarterly sales and slashed FY24 revenue forecast.
    • Shares of Hertz Global Holdings, Inc. (NASDAQ:HTZ) were down 24% to $4.4250 after the company mixed first-quarter financial results.
    • Orion Group Holdings, Inc. (NYSE:ORN) was down, falling 20% to $6.38 following weak quarterly sales.

    Also Check This Out: Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday

    Commodities

    In commodity news, oil traded down 0.7% to $82.26 while gold traded up 0.1% at $2,339.30.

    Silver traded up 0.1% to $27.36 on Thursday, while copper rose 2.1% to $4.5525.

    Euro zone

    European shares were mostly lower today. The eurozone's STOXX 600 fell 0.79%, London's FTSE 100 rose 0.29% while Spain's IBEX 35 Index fell 0.78% The German DAX fell 1.18% French CAC 40 fell 1.18% while Italy's FTSE MIB Index fell 1.07%.

    Producer prices in Spain fell 8.2% year-over-year in March compared to a revised 8.5% decline in February. The GfK Consumer Climate Indicator for Germany climbed to -24.2 heading into May versus a revised reading of -27.3 in the prior period. UK's car production fell 27.1% to 59,467 units for March.

    Asia Pacific Markets

    Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 falling 2.16%, Hong Kong's Hang Seng Index gaining 0.48%, China's Shanghai Composite climbing 0.27% and India's S&P BSE Sensex gaining 0.66%.

    Hong Kong's trade deficit increased to $45.0 billion in March from $40.6 billion in the year-ago month. The index of leading economic indicators in Japan came in unchanged at 111.8 in February, while index of coincident economic indicators was revised higher to 111.6 in February versus a flash reading of 110.9.

    Economics

    • U.S. initial jobless claims declined by 5,000 to 207,000 in the week ending April 20, compared to market estimates of 214,000.
    • The U.S. economy grew an annualized 1.6% in the first quarter, marking a notable slowdown from the 3.4% rate in the final quarter of 2023. However, analysts were expecting a 2.5% growth.
    • U.S. wholesale inventories fell by 0.4% month-over-month in March compared to a revised 0.4% gain in February.
    • Pending home sales in the U.S. climbed by 3.4% month-over-month in March.
    • The core price index for personal consumption expenditures increased by an annualized 3.7% in the first quarter versus a 2% gain in the prior three-month period.
    • The EIA said US natural-gas supplies rose 92 billion cubic feet during the week ended April 19.

    Now Read This: Jim Cramer: You’re ‘Dice Rolling’ With This Biopharma Stock, But Vista Energy Is ‘A Good Situation’

    Get the next $ATNI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATNI
    $HTZ
    $MRK
    $ORN

    CompanyDatePrice TargetRatingAnalyst
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    Orion Group Holdings Inc. Common
    $ORN
    1/22/2026$16.00Overweight
    Analyst
    Merck & Company Inc.
    $MRK
    1/8/2026$135.00Peer Perform → Outperform
    Wolfe Research
    Merck & Company Inc.
    $MRK
    12/18/2025$130.00Market Perform → Outperform
    BMO Capital Markets
    Merck & Company Inc.
    $MRK
    11/24/2025$125.00Equal Weight → Overweight
    Wells Fargo
    Merck & Company Inc.
    $MRK
    11/13/2025$105.00Sector Outperform
    Scotiabank
    Impinj Inc.
    $PI
    11/7/2025$200.00Neutral
    UBS
    Merck & Company Inc.
    $MRK
    10/13/2025$95.00Neutral
    Citigroup
    More analyst ratings

    $ATNI
    $HTZ
    $MRK
    $ORN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Whitmore Bradford T bought $300,902 worth of shares (53,000 units at $5.68) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    12/16/25 4:32:26 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Director Goddard Janie bought $9,999 worth of Common Stock; $.10 par value (1,739 units at $5.75), increasing direct ownership by 29% to 7,668 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    12/15/25 4:10:29 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Director Robert W. Shaw bought $9,922 worth of Common Stock; $.10 par value (1,750 units at $5.67), increasing direct ownership by 3% to 71,000 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    11/26/25 9:58:19 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ATNI
    $HTZ
    $MRK
    $ORN
    SEC Filings

    View All

    SEC Form S-8 filed by Impinj Inc.

    S-8 - IMPINJ INC (0001114995) (Filer)

    2/9/26 4:40:30 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    SEC Form 10-K filed by Impinj Inc.

    10-K - IMPINJ INC (0001114995) (Filer)

    2/9/26 4:16:02 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Impinj Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - IMPINJ INC (0001114995) (Filer)

    2/5/26 4:18:25 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    $ATNI
    $HTZ
    $MRK
    $ORN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Impinj Reports Fourth Quarter and Full Year 2025 Financial Results

    Impinj, Inc. (NASDAQ:PI), a leading RAIN RFID provider and Internet of Things pioneer, today released its financial results for the fourth quarter and year ended December 31, 2025. "2025 was a transition year for Impinj. We grew year-over-year endpoint IC volumes, made M800 our volume runner, launched Gen2X and exited the year with record adjusted EBITDA and cash," said Chris Diorio, Impinj co-founder and CEO. "As we continue driving our bold vision, I remain confident in our market position and energized by the opportunities ahead." Fourth Quarter 2025 Financial Summary Revenue of $92.8 million GAAP gross margin of 51.8%; non-GAAP gross margin of 54.5% GAAP net loss of $1.1 mi

    2/5/26 4:15:00 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Merck Announces Health Canada Approval of ENFLONSIA® for the prevention of RSV in newborns and infants

    Approval is based on the CLEVER and SMART Clinical Trial Results KIRKLAND, QC, Feb. 5, 2026 /CNW/ -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Health Canada has approved ENFLONSIA® (clesrovimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and infants born during or entering their first RSV season. ENFLONSIA® is a monoclonal antibody (mAb) that can help provide protection for up to five months—typical of an RSV season. The Health Canada approval marks an important

    2/5/26 7:05:00 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Orion Completes Acquisition of J. E. McAmis, Strengthening Heavy Marine, Jetty and Breakwater Construction Capabilities

    HOUSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE:ORN) (the "Company" or "Orion"), a leading specialty construction company, today announced that it has acquired J. E. McAmis, Inc. and JEM Marine Leasing LLC (together, "J.E. McAmis" or "McAmis"), for approximately $60 million, net of cash acquired. Transaction Highlights Advances Orion's long-term strategic growth plan and fortifies Orion's competitive position ahead of significant marine opportunities on the horizon Strengthens Orion's marine construction business with best-in-class jetty and breakwater construction capabilities with a proven track record in complex project delivery Enhances Orion's equipment f

    2/4/26 6:59:00 AM ET
    $ORN
    Military/Government/Technical
    Industrials

    $ATNI
    $HTZ
    $MRK
    $ORN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Marketing Officer Guindo Chirfi sold $1,184,101 worth of shares (10,000 units at $118.41), decreasing direct ownership by 12% to 70,615 units (SEC Form 4)

    4 - Merck & Co., Inc. (0000310158) (Issuer)

    2/9/26 4:04:59 PM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, General Counsel Zachary Jennifer exercised 121,573 shares at a strike of $119.15 and sold $14,485,690 worth of shares (121,573 units at $119.15) (SEC Form 4)

    4 - Merck & Co., Inc. (0000310158) (Issuer)

    2/9/26 4:01:25 PM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP,Chief Info&Digital Officer Williams David Michael exercised 5,000 shares at a strike of $77.62 and sold $609,525 worth of shares (5,000 units at $121.91), decreasing direct ownership by 0.00% to 30,838 units (SEC Form 4)

    4 - Merck & Co., Inc. (0000310158) (Issuer)

    2/6/26 4:20:14 PM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNI
    $HTZ
    $MRK
    $ORN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Impinj downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Impinj from Outperform to In-line and set a new price target of $112.00

    2/6/26 8:09:28 AM ET
    $PI
    Industrial Machinery/Components
    Technology

    Analyst initiated coverage on Orion Group with a new price target

    Analyst initiated coverage of Orion Group with a rating of Overweight and set a new price target of $16.00

    1/22/26 8:30:05 AM ET
    $ORN
    Military/Government/Technical
    Industrials

    Merck upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Merck from Peer Perform to Outperform and set a new price target of $135.00

    1/8/26 8:11:51 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNI
    $HTZ
    $MRK
    $ORN
    Financials

    Live finance-specific insights

    View All

    Impinj Reports Fourth Quarter and Full Year 2025 Financial Results

    Impinj, Inc. (NASDAQ:PI), a leading RAIN RFID provider and Internet of Things pioneer, today released its financial results for the fourth quarter and year ended December 31, 2025. "2025 was a transition year for Impinj. We grew year-over-year endpoint IC volumes, made M800 our volume runner, launched Gen2X and exited the year with record adjusted EBITDA and cash," said Chris Diorio, Impinj co-founder and CEO. "As we continue driving our bold vision, I remain confident in our market position and energized by the opportunities ahead." Fourth Quarter 2025 Financial Summary Revenue of $92.8 million GAAP gross margin of 51.8%; non-GAAP gross margin of 54.5% GAAP net loss of $1.1 mi

    2/5/26 4:15:00 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Orion Completes Acquisition of J. E. McAmis, Strengthening Heavy Marine, Jetty and Breakwater Construction Capabilities

    HOUSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE:ORN) (the "Company" or "Orion"), a leading specialty construction company, today announced that it has acquired J. E. McAmis, Inc. and JEM Marine Leasing LLC (together, "J.E. McAmis" or "McAmis"), for approximately $60 million, net of cash acquired. Transaction Highlights Advances Orion's long-term strategic growth plan and fortifies Orion's competitive position ahead of significant marine opportunities on the horizon Strengthens Orion's marine construction business with best-in-class jetty and breakwater construction capabilities with a proven track record in complex project delivery Enhances Orion's equipment f

    2/4/26 6:59:00 AM ET
    $ORN
    Military/Government/Technical
    Industrials

    Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline

    Reports Strength in Oncology and Animal Health, Plus Increasing Contributions From WINREVAIR and CAPVAXIVE Fourth-Quarter Worldwide Sales Were $16.4 Billion (5% Growth; 4% Growth ex-FX) Fourth-Quarter GAAP EPS Was $1.19; Non-GAAP EPS Was $2.04; GAAP and Non-GAAP EPS Include a Charge of $0.05 per Share for the Acquisition of MK-8690 Sole Global Rights Full-Year Worldwide Sales Were $65.0 Billion (1% Growth; 2% Growth ex-FX) KEYTRUDA/KEYTRUDA QLEX Sales Were $31.7 Billion (7% Growth Both Nominally and ex-FX); Includes KEYTRUDA QLEX Sales of $40 Million WINREVAIR Sales Were $1.4 Billion CAPVAXIVE Sales Were $759 Million GARDASIL/GARDASIL 9 Sales Were $5.2 Billion (39% Decli

    2/3/26 6:30:00 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNI
    $HTZ
    $MRK
    $ORN
    Leadership Updates

    Live Leadership Updates

    View All

    Alaska Communications Strengthens Carrier & Wholesale Services with New Leadership

    Alaska Communications is enhancing its carrier and wholesale services organization to deliver greater value for partners and customers with the appointment of Jesse Kleinbach as the new vice president of the organization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260119649040/en/Pictured: Jesse Kleinbach. With more than 25 years in telecom, Kleinbach brings expertise in creating solutions that help partners succeed. He has led initiatives that simplify connectivity, expand market opportunities, and ensure customers receive reliable, innovative services. In his new role, Kleinbach will focus on expanding service options, i

    1/19/26 11:00:00 AM ET
    $ATNI
    Telecommunications Equipment
    Telecommunications

    Alaska Communications Welcomes John Sims to Board of Directors

    Alaska Communications is pleased to announce the appointment of John Sims, President of ENSTAR Natural Gas Company, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124343374/en/Pictured: John Sims. Born and raised in Eagle River, Sims brings deep Alaska roots and a lifelong commitment to serving the unique needs of Alaskans. His extensive leadership experience, including nearly two decades at ENSTAR, reflects a proven ability to guide organizations through growth and challenges while keeping community at the forefront. Under his leadership, ENSTAR has strengthened its role as a trusted energy provider

    11/24/25 2:20:00 PM ET
    $ATNI
    Telecommunications Equipment
    Telecommunications

    Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent

    CD388 is an investigational long-acting, strain-agnostic antiviral agent currently in Phase 3, designed to prevent influenza infection in individuals at higher risk of influenza complications Acquisition aligns with Merck's science-led business development strategy, diversifying and expanding the company's pipeline Merck (NYSE:MRK), known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. (NASDAQ:CDTX) ("Cidara"), a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for $221.50 per share in cash, for a tot

    11/14/25 6:45:00 AM ET
    $CDTX
    $MRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ATNI
    $HTZ
    $MRK
    $ORN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Orion Group Holdings Inc. Common

    SC 13G/A - Orion Group Holdings Inc (0001402829) (Subject)

    11/14/24 12:13:19 PM ET
    $ORN
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13D/A filed by Impinj Inc.

    SC 13D/A - IMPINJ INC (0001114995) (Subject)

    11/12/24 4:46:57 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SC 13G/A filed by Impinj Inc.

    SC 13G/A - IMPINJ INC (0001114995) (Subject)

    11/12/24 3:56:16 PM ET
    $PI
    Industrial Machinery/Components
    Technology